CYNTHIA DREW: Open Payments
NPI 1508893751 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,157 in 11 payments from 8 companies in 2025. Trend: 2023 $928 · 2024 $307 · 2025 $1,157
Food & beverage: $1,157
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $229 |
| Lundbeck LLC | 3 | $229 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $155 |
| Alnylam Pharmaceuticals Inc. | 1 | $146 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $124 |
| ViiV Healthcare Company | 1 | $23 |
Products named: Kerendia, AMVUTTRA, BREZTRI, VOQUEZNA, Auvelity, VYEPTI, REXULTI.
Industry payments across FL — which companies pay providers there.
